LYMTACs: Chimeric Small Molecules Repurpose Lysosomal Membrane Proteins for Target Protein Relocalization and Degradation
Dhanusha A. Nalawansha(Amgen (United States)), Patrick Ryan Potts(St. Jude Children's Research Hospital)
Cited by 0
Related Papers
Structural basis for substrate recognition and chemical inhibition of oncogenic MAGE ubiquitin ligases
|Nature Communications|2020|26
LYMTACs:chimeric small molecules repurpose lysosomal membrane proteins for target protein relocalization and degradation
|Nature Communications|2025|9
Enhanced stress tolerance through reduction of G3BP and suppression of stress granules
|bioRxiv (Cold Spring Harbor Laboratory)|2020|1